NCT04101396

Brief Summary

This study aims to compare between 4 and 7 points blood glucose monitoring in women with gestational diabetes on diet modification.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 24, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

October 25, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

2.7 years

First QC Date

September 17, 2019

Last Update Submit

November 7, 2023

Conditions

Keywords

diet modification, 4 and 7 points monitoring

Outcome Measures

Primary Outcomes (25)

  • Pregnancy outcome of participants

    Mean gestational age at delivery in weeks

    From date of randomisation up to 40 weeks gestation

  • Pregnancy outcome of participants

    Rate of spontaneous or induced labour in percentage

    From date of randomisation up to 40 weeks gestation and participants are diagnosed in established labour

  • Pregnancy outcome of participants

    Rate of vaginal, instrumental or caesarean delivery in percentage

    From date of randomisation up to 40 weeks gestation when the participants had given birth to the newborn

  • Pregnancy outcome of participants

    Rate of intrapartum complications such as postpartum haemorrhage, shoulder dystocia and third or fourth degree tear in percentage

    From date of randomisation up to 40 weeks gestation during progress of labour up to 24 hours post delivery

  • Pregnancy outcome of participants

    Mean neonatal birth weight in kilogram

    At the point of birth of the neonate

  • Pregnancy outcome of participants

    Rate of neonates born with Apgar score at five minutes of less than 7 in percentage

    At the point of birth of the neonate

  • Pregnancy outcome of participants

    Rate of neonatal intensive care unit admission in percentage

    At the point of birth of the neonate

  • Pregnancy outcome of participants

    Rate of neonatal complications such as intrauterine fetal demise, neonatal death, neonatal hypoglycaemia, neonatal jaundice, neonatal respiratory distress syndrome and neonatal sepsis in percentage

    From date of randomisation up to 7 days after birth of the neonate

  • Demographic data of participants

    Mean age of participants in years

    On the date of randomisation

  • Demographic data of participants

    Rate of each different races such as Malay, Chinese and Indian in percentage

    On the date of randomisation

  • Demographic data of participants

    Rate of parity such as nulliparous or multiparous in percentage

    On the date of randomisation

  • Demographic data of participants

    Mean prepregnancy body mass index in kg/m\^2

    On the date of randomisation up to 40 weeks gestation based on the first trimester weight documented in the antenatal record

  • Demographic data of participants

    Mean total weight gain in kilogram

    On the date of randomisation till 40 weeks gestation

  • Demographic data of participants

    Rate of positive family history of diabetes mellitus in percentage

    On the date of randomisation up to 40 weeks gestation

  • Demographic data of participants

    Rate of previous pregnancy affected by gestational diabetes mellitus in percentage

    On the date of randomisation up to 40 weeks gestation

  • Demographic data of participants

    Rate of previous pregnancy complicated by fetal macrosomia in percentage

    On the date of randomisation up to 40 weeks gestation

  • Clinical characteristics of participants

    Mean gestational age gestational diabetes mellitus is diagnosed in weeks

    On the date of randomisation up to 40 weeks gestation

  • Clinical characteristics of participants

    Mean fasting glucose level from the modified glucose tolerance test in mmol/l

    On the date of randomisation up to 40 weeks gestation

  • Clinical characteristics of participants

    Mean two hours post 75 gram glucose load from the modified glucose tolerance test in mmol/l

    On the date of randomisation up to 40 weeks gestation

  • Clinical characteristics of participants

    Rate of antenatal complications such as preeclampsia, threatened preterm labour, preterm prelabour rupture of membranes, anaemia,

    At the point of randomisation till 40 weeks gestation

  • Clinical characteristics of participants

    Mean level of glycosylated haemoglobin in percentage

    At the point of randomisation till 40 weeks gestation

  • Clinical characteristics of participants

    Mean level of serum fructosamine in percentage

    At the point of randomisation till 40 weeks gestation

  • Clinical characteristics of participants

    Mean level of fasting blood glucose in self monitoring blood glucose in mmol/l

    At the point of randomisation till 40 weeks gestation

  • Clinical characteristics of participants

    Mean level of pre-meal blood glucose in self monitoring blood glucose in mmol/l

    At the point of randomisation till 40 weeks gestation

  • Clinical characteristics of participants

    Mean level of one hour post-meal blood glucose in self monitoring blood glucose in mmol/l

    At the point of randomisation till 40 weeks gestation

Secondary Outcomes (4)

  • Requirement of treatment in participants

    From the date of randomisation up to 40 weeks gestation

  • Requirement of treatment in participants

    From point of randomisation till 40 weeks gestation

  • Participants' compliance

    From point of randomisation till 40 weeks gestation

  • Participants' satisfaction

    From point of randomisation till 40 weeks gestation

Study Arms (2)

4 points blood glucose monitoring

OTHER

4 points of self monitoring blood glucose which comprises of fasting, 1 hour post breakfast, 1 hour post lunch and 1 hour post dinner

Dietary Supplement: diabetic diet

7 points blood glucose monitoring

OTHER

7 points of self monitoring blood glucose which comprises of fasting,1 hour post breakfast, 1 hour pre and post lunch, 1 hour pre and post dinner, pre bed at 10 pm

Dietary Supplement: diabetic diet

Interventions

diabetic dietDIETARY_SUPPLEMENT

Patients with gestational diabetes will be seen by the dietitian to be taught diet modification

4 points blood glucose monitoring7 points blood glucose monitoring

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-45 years old
  • Pregnant women with gestational diabetes mellitus on diet modification
  • Confirmed gestational diabetes mellitus using National Institute for Health and Care Excellence guideline by 75g oral glucose tolerance test after 14 weeks
  • Gestational age at recruitment 20-34 week

You may not qualify if:

  • bad obstetrics history.
  • Women with underlying medical disorders such as hypertension, autoimmune diseases on steroids
  • fetal anomaly.
  • Women planning to deliver in other centres
  • Women who refuse to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Antenatal clinic, UKM Medical Centre

Cheras, Kuala Lumpur, 56000, Malaysia

Location

National University of Malaysia

Cheras, Kuala Lumpur, 56000, Malaysia

Location

Related Publications (1)

  • Berohan ND, Alias H, Ishak S, Mohammed Nawi A, Azman N, Sohaimi D, Kamisan Atan I, Abd Wahab N, Kalok AH, Mohamad AS, Abd Rahman R. 4 vs 7 points self-monitoring blood glucose in gestational diabetes mellitus on diet modification: randomised clinical trial in a single tertiary centre in Malaysia. Arch Gynecol Obstet. 2024 Oct;310(4):1959-1965. doi: 10.1007/s00404-024-07661-5. Epub 2024 Aug 7.

MeSH Terms

Interventions

Diet, Diabetic

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Noor Dalila Berohan

    National University of Malaysia

    PRINCIPAL INVESTIGATOR
  • Norasyikin Abd Wahab

    National University of Malaysia

    STUDY DIRECTOR
  • Shuhaila Ahmad

    National University of Malaysia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: All women with gestational diabetes are randomised to 4 or 7 points of self monitoring blood glucose.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 17, 2019

First Posted

September 24, 2019

Study Start

October 25, 2019

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

November 9, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

The IPD will only be shared upon request. The data that can be shared will be the blood glucose levels and pregnancy outcomes.

Locations